Skip to content

Discontinued — last reported Q2 '19

Gross margin at other companies

Eli Lilly logo
Eli LillyLLY
82.8%+1.1pp
Amgen logo
AmgenAMGN
68.3%+5.3pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
98.4%-0.2pp
Moderna logo
ModernaMRNA
22.1%-32.0pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
89.7%+1.5pp

Other financials

Income statement

See full
Revenue$136.0M-2.2%
Operating income-$169.0M-18.2%
Net income-$185.0M-22.5%
EPS (diluted)-$1.84-17.2%

Balance sheet

See full
Cash & equivalents$175.0M+37.8%
Total debt$36.0M-10.8%
Total equity-$236.0M-264%
Total assets$1.3B-1.2%

Cash flow

See full
Operating cash flow-$197.0M-18.7%
CapEx$1.0M0.0%
Free cash flow-$198.0M-18.6%

Valuation

See full
Market cap$2.83B-39.4%
P/S4.2×-3.7×

Profitability

See full
Operating margin-83.8%-3.0pp
Net margin-90.9%-2.1pp
FCF margin-75.1%+10.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×
Current ratio-0.4×

Where this comes from

Calculated from Ultragenyx Pharmaceutical’s reported figures.

Based on trailing twelve months.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed July 30, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.